Wolfgang Miesbach/LinkedIn
Apr 19, 2026, 13:42
Wolfgang Miesbach: Key Insights on Hemophilia Care at WFH 2026 Pre-Congress Workshop
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”Great start to the pre‑congress workshop ‘Safety, Efficacy, and Access in Hemophilia and Rare Bleeding Disorders’ at WFH 2026 in Kuala Lumpur this morning, expertly chaired by Radoslaw (Radek) Kaczmarek.
Even though I missed the most, I caught excellent talks and discussion on the last part about haemostatic agents, prophylaxis, and their impact on everyday practice.
The session on how and when to start which type of prophylaxis – with great presentations by Steve Pipe and Manuel Carcao – will strongly inform day‑to‑day decisions and individualized care.”
Stay updated with Hemostasis Today.
-
Jun 11, 2026, 08:35Mohamed Reda: CBC Report – More Than Just Numbers
-
Jun 11, 2026, 07:59Uday Sankar Akash Vankayala: Key Findings on IBD-Associated VTE Phenotypes and Inpatient Burden
-
Jun 11, 2026, 07:41Zia Ullah: Hidden Cerebral Venous Sinus Thrombosis After Dengue Recovery
-
Jun 11, 2026, 07:24Aaron Rodriguez Calienes: RESISTANT Registry Provides Reassuring Safety Data for Acute Intracranial Stenting
-
Jun 11, 2026, 07:17Mbunya. S. Misiani: From the WFH Congress to Meaningful Change for Patients with Bleeding Disorders Worldwide
-
Jun 11, 2026, 07:06Bernard Slater Jr.: Hemophilia B Reminds You that No Matter How Strong You Are, You Are Still Human
-
Jun 11, 2026, 05:11Daniel I McIsaac: Less Blood Loss and No Excess VTE with Tranexamic Acid in High-Risk Surgery
-
Jun 11, 2026, 05:03Aymeric Couturier: Lessons from the TRACK Trial on Anticoagulation in Advanced CKD
-
Jun 11, 2026, 04:53Umut Kocabas: Current Practice and Guideline Adherence on Cancer-Associated Thrombosis in Turkey